Your browser doesn't support javascript.
loading
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.
Watkins, Melynda E; Wring, Steve; Randolph, Ryan; Park, Seonghee; Powell, Kendall; Lutz, Lissa; Nowakowski, Michelle; Ramabhadran, Ram; Domanico, Paul L.
Afiliação
  • Watkins ME; The Clinton Health Access Initiative, Research and Development, Boston, Massachusetts 02127.
  • Wring S; SCYNEXIS, Inc., Jersey City, New Jersey 07302.
  • Randolph R; SCYNEXIS, Inc., Jersey City, New Jersey 07302.
  • Park S; SCYNEXIS, Inc., Jersey City, New Jersey 07302.
  • Powell K; SCYNEXIS, Inc., Jersey City, New Jersey 07302.
  • Lutz L; The Clinton Health Access Initiative, Research and Development, Boston, Massachusetts 02127.
  • Nowakowski M; The Clinton Health Access Initiative, Research and Development, Boston, Massachusetts 02127.
  • Ramabhadran R; The Clinton Health Access Initiative, Research and Development, Boston, Massachusetts 02127.
  • Domanico PL; The Clinton Health Access Initiative, Research and Development, Boston, Massachusetts 02127. Electronic address: pdomanico@clintonhealthaccess.org.
J Pharm Sci ; 106(3): 906-919, 2017 03.
Article em En | MEDLINE | ID: mdl-27986599

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Fármacos Anti-HIV / Tenofovir / Absorção Intestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharm Sci Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Fármacos Anti-HIV / Tenofovir / Absorção Intestinal Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: J Pharm Sci Ano de publicação: 2017 Tipo de documento: Article